TECNOSCENT
Dissolution or liquidationSummary
The KBO register records for TECNOSCENT the legal situation: dissolution or liquidation; this is today's state according to the register itself, which carries no start date. The 2025 annual accounts show negative equity (-€16,224) and a net result of -€12.
Signals
Three signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year -€16,224
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
32 d early
2024
29 d early
2023
48 d early
2022
33 d early
2021
52 d early
2020
52 d early
2019
60 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 27 days before the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
Who ran this company, and where was it based, on a date before the end?Company as of a date How is the Other research and development on natural sciences sector doing?Sector figures
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€12▲ 96.7%
2024 · -€363
Working capital
-€15,592▼ 0.1%
2024 · -€15,580
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result-€73▲ 98.6%-€2,076▼ 2,744%-€3,085▼ 48.6%-€363▲ 88.2%-€12▲ 96.7%
Net result-€73within the sector's middle half▲ 98.6%-€2,076within the sector's middle half▼ 2,744%-€3,085within the sector's middle half▼ 48.6%-€363within the sector's middle half▲ 88.2%-€12within the sector's middle half▲ 96.7%
Equity-€10,689below the sector's middle half▼ 0.7%-€12,765below the sector's middle half▼ 19.4%-€15,850below the sector's middle half▼ 24.2%-€16,212below the sector's middle half▼ 2.3%-€16,224below the sector's middle half▼ 0.1%
Total assets€9,297below the sector's middle half▼ 35.6%€7,297below the sector's middle half▼ 21.5%€7,212below the sector's middle half▼ 1.2%€3,934below the sector's middle half▼ 45.4%€3,761below the sector's middle half▼ 4.4%
Debt€19,985▼ 20.2%€20,061▲ 0.4%€23,061▲ 15.0%€20,146▼ 12.6%€19,985▼ 0.8%
Working capital-€10,057below the sector's middle half▼ 0.7%-€12,133below the sector's middle half▼ 20.6%-€15,218below the sector's middle half▼ 25.4%-€15,580below the sector's middle half▼ 2.4%-€15,592below the sector's middle half▼ 0.1%
Solvency-115.0%below the sector's middle half▼ 41.5pp-174.9%below the sector's middle half▼ 60.0pp-219.8%below the sector's middle half▼ 44.8pp
Current ratio0.48below the sector's middle half▼ 0.110.38below the sector's middle half▼ 0.100.32below the sector's middle half▼ 0.05
Return on assets (ROA)-0.8%within the sector's middle half▲ 34.3pp-28.5%below the sector's middle half▼ 27.7pp-42.8%below the sector's middle half▼ 14.3pp
above
within
below
the middle half (P25 to P75) of NACE 72, Scientific research and development, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €12 in 2025 against €363 in 2024; the loss shrinks.
Key figures and ratios
Debt ≤ 1 year
€19,354▼
2024 · €19,515
Ratios withheld: a balance sheet total of €3,761 is too small for a meaningful ratio.
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Gross operating margin9900 | -€73 | -€2,076 | -€3,085 | -€363 | -€12 | ▲ 96.7% |
| Operating profit (loss)9901 | -€73 | -€2,076 | -€3,085 | -€363 | -€12 | ▲ 96.7% |
| Profit (loss) for the period before taxes9903 | -€73 | -€2,076 | -€3,085 | -€363 | -€12 | ▲ 96.7% |
| Profit (loss) for the period9904 | -€73 | -€2,076 | -€3,085 | -€363 | -€12 | ▲ 96.7% |
| Profit (loss) for the period to be appropriated9905 | -€73 | -€2,076 | -€3,085 | -€363 | -€12 | ▲ 96.7% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €9,297 | €7,297 | €7,212 | €3,934 | €3,761 | ▼ 4.4% |
| Current assets29/58 | €9,297 | €7,297 | €7,212 | €3,934 | €3,761 | ▼ 4.4% |
| Amounts receivable within one year40/41 | €9,297 | €7,297 | €7,212 | €3,934 | €3,761 | ▼ 4.4% |
| Other amounts receivable41 | €9,297 | €7,297 | €7,212 | €3,934 | €3,761 | ▼ 4.4% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €9,297 | €7,297 | €7,212 | €3,934 | €3,761 | ▼ 4.4% |
| Equity10/15 | -€10,689 | -€12,765 | -€15,850 | -€16,212 | -€16,224 | ▼ 0.1% |
| Contributions10/11 | €7.3m | €7.3m | €7.3m | €7.3m | €7.3m | = |
| Capital10 | €7.3m | €7.3m | €7.3m | €7.3m | €7.3m | = |
| Issued capital100 | €7.3m | €7.3m | €7.3m | €7.3m | €7.3m | = |
| Profit (loss) carried forward14 | -€7.3m | -€7.3m | -€7.3m | -€7.3m | -€7.3m | = |
| Amounts payable17/49 | €19,985 | €20,061 | €23,061 | €20,146 | €19,985 | ▼ 0.8% |
| Amounts payable within one year42/48 | €19,354 | €19,430 | €22,430 | €19,515 | €19,354 | ▼ 0.8% |
| Trade debts44 | - | €76 | €3,076 | €161 | - | - |
| Suppliers440/4 | - | €76 | €3,076 | €161 | - | - |
| Other amounts payable47/48 | €19,354 | €19,354 | €19,354 | €19,354 | €19,354 | = |
| Accrued charges and deferred income492/3 | €632 | €632 | €632 | €632 | €632 | = |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€73 | -€2,076 | -€3,085 | -€363 | -€12 | ▲ 96.7% |
| Operating cash flow (approximation) | -€73 | -€2,076 | -€3,085 | -€363 | -€12 | ▲ 96.7% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
29-06
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
02-07
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
13-06
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
28-06
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
09-06
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
09-06
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
31-12
Financial
Weakest financial yearnet -€5,073
Net result drops to -€5,073, the lowest in the series.
29-09
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 60 days late
2019
28-06
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
09-07
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
2017
20-06
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 6 acts read
About the unread acts
We know of 6 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Anderlecht
Ground area
1,843 m²
Building footprint
487 m²
Volume, LiDAR
3,582 m³
Parcel 21307E0036/00B003, Brussels · tallest building 20.9 m, ±2 floors. Linked by address, not a title deed.
5
companies at this address
See who is registered here
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21307E0036/00B003 | Brussels | 1,843 m² | 1 · 487 m² | 20.9 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 ownerOwners 1
- Sourceaccounts CHEMCOM 202550%
Holdings 0
No holding stated in the accounts, acts or LEI register we read.
According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Similar companies · same sector and region
Accessible and Affordabmle Laboratory solutions For All
BE 1007.847.123
Anderlecht
Aetech Medical
BE 1027.053.519
Anderlecht
Brussels Medical Device Center
BE 0663.935.801
Anderlecht
FYTEKO
BE 0552.915.242
Anderlecht
INNOVATIVE MICROBIAL BIOPROCESS
BE 0477.640.767
Anderlecht
This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of 1,177 companies in sector 72109 we hold annual accounts for 717. See the whole sector
Identification & contact
Identification
Legal formPublic limited company
Founded19-04-2007
Fiscal year end31-12
Activities, NACEBEL 2025
72109Other research and development on natural sciences
72200Scientific research and development
E-invoicing
Reachable via Peppol
Peppol ID
0208:0888870188
Registered
19-12-2025
The company is no longer active; its Peppol card can remain until its access point withdraws it.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.